University of Kansas
Liang Xu is an Associate Professor in the Department of Molecular Biosciences at University of Kansas
Molecular therapy targeting cancer and cancer stem cells, cancer biology, drug discovery and drug/gene delivery. Funded by multiple NIH and DOD grants, his lab is working on molecularly targeted cancer therapy and chemo/radiosensitization by modulating cell death signaling pathways, autophagy and apoptosis. We are exploring microRNAs as novel targets for cancer and cancer stem cells. Novel nanotechnology to develop nanovectors targeting cancer stem cells and exploring novel molecular therapy for cancer stem cells.